Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching.
about
Chronic HCV infection: epidemiological and clinical relevanceNeoplastic disease after liver transplantation: Focus on de novo neoplasmsTransplant benefit for patients with hepatocellular carcinomaDeceased donor risk factors influencing liver transplant outcomeLiver transplantation in adults: Choosing the appropriate timingCost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent Hepatitis.Antibody-mediated rejection after adult living-donor liver transplantation triggered by positive lymphocyte cross-match combinationRecurrent hepatitis C virus infection post liver transplantation: impact of choice of calcineurin inhibitor.A Multistep, Consensus-Based Approach to Organ Allocation in Liver Transplantation: Toward a "Blended Principle Model".Impact of hepatitis C virus infection on health-related quality of life before and after liver transplantation: a multidisciplinary point of view.International comparison of liver transplant programmes: differences in indications, donor and recipient selection and outcome between Italy and UK.Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: a real-life strategy.Optimal timing for hepatitis C therapy in US patients eligible for liver transplantation: a cost-effectiveness analysis.Cost-effectiveness of pretransplant sofosbuvir for preventing recurrent hepatitis C virus infection after liver transplantation.Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor.The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience.Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients.Donor factors similarly impact survival outcome after liver transplantation in hepatocellular carcinoma and non-hepatocellular carcinoma patients.Results of a newborn liver transplant program in the era of piggyback technique and extended donor criteria in Italy.Successful donation after cardiac death liver transplants with prolonged warm ischemia time using normothermic regional perfusion.Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C.Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation?Priority of candidates with hepatocellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapyHepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study
P2860
Q21261812-06424C19-8D20-4B93-AD4E-FD496EED7BEBQ26798306-488FA241-FD51-47E4-BDB9-694D39D30429Q26861543-A4117891-D6BD-4E1C-B0AB-F32A589513CDQ27003929-4EEF7ADB-4E60-4A60-9B74-877EAF2ADD2DQ36220176-7A9322E0-521B-4A56-A329-CD223051AA48Q37098646-B34AFF4E-C6DF-47EA-814C-9A7096709A69Q37647235-9A7C6673-07C8-42C4-BDFA-4C0B9C55D156Q38081919-4CE09EC0-90A1-4A27-8390-42E3D510FED6Q38566746-36EF8FF8-5B88-420F-94F1-1D0B5A48C776Q38653173-B4C9F6CB-F0E6-4A5A-A33D-689A00DCA269Q39877533-3A487818-5D01-4D2C-BC4C-0E79ECC21300Q40444467-09A9728E-68D8-4453-842E-95BABE0C9DC6Q40576603-E41409A6-8C57-490A-96EC-16BC2ACB4F90Q41085476-853E8F8C-85F6-4508-957B-54E14E438876Q41578261-31E4DAF2-F90E-4453-9794-D5893D605B1BQ41997021-E6245523-3D1A-410D-AC15-1C32D4B3A68CQ42227512-8590DD47-BE90-42F8-8AB1-D6011793EB35Q43040549-AB3ABC8A-F805-4F1D-BE71-55322C128813Q44653651-CA4B5C10-1F7A-4AE1-84F0-FDC029B3DE10Q45384147-9E662AD0-8664-4A7C-8CBD-6EA00B76AD67Q50279062-DE67A0F5-AA39-4840-9C32-3F51197C071AQ50552857-76A5C834-6560-48FA-AFD0-465EF13A02AAQ51558703-3418C6C5-68E1-40C4-9A2D-9A8C02DC60FEQ56984103-1E556CE3-D001-40A9-9DA9-157FE585AFB1Q57815092-57D21BDE-DFDE-4881-B408-0A172AC9A4A9
P2860
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Liver Match, a prospective obs ...... e of donor-recipient matching.
@en
Liver Match, a prospective obs ...... e of donor-recipient matching.
@nl
type
label
Liver Match, a prospective obs ...... e of donor-recipient matching.
@en
Liver Match, a prospective obs ...... e of donor-recipient matching.
@nl
prefLabel
Liver Match, a prospective obs ...... e of donor-recipient matching.
@en
Liver Match, a prospective obs ...... e of donor-recipient matching.
@nl
P2093
P50
P1476
Liver Match, a prospective obs ...... e of donor-recipient matching.
@en
P2093
Alessandra Nardi
Alessandro Nanni Costa
Andrea Risaliti
Antonio Gasbarrini
Antonio Pinna
Bruno Gridelli
Caius Gavrila
Fausto Zamboni
Fulvio Calise
Giuseppe Tisone
P304
P356
10.1016/J.DLD.2010.11.002
P50
P577
2010-12-24T00:00:00Z